DermTech, Inc. (DMTK) Covered Calls

You can sell covered calls on DermTech, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for DMTK (prices last updated Thu 3:25 PM ET):

DermTech, Inc. (DMTK) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
0.62 0.00 0.62 0.63 54K - 0.0
Covered Calls For DermTech, Inc. (DMTK)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 2.5 0.00 0.63 0.0% 0.0%
Jun 21 2.5 0.00 0.63 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive diagnostic tests to diagnosis skin cancer and related conditions in the United States. The company offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. It also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. The company is also developing non-melanoma skin cancer diagnostic and non-melanoma skin cancer risk assessment products. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.